MedTrace Logo

Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali

NCT02311387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 601

Last updated 2019-12-12

No results posted yet for this study

Summary

Background:

\- Lassa fever is very similar to other diseases that cause fever, such as malaria and yellow fever. People get Lassa fever from mice. A person can get Lassa fever from mice urine and droppings. When a group of researchers tested the mice in Soromba, Mali, they found that many were infected with Lassa fever. Lassa fever may also be passed through body fluids (like blood or semen) of people infected with Lassa fever. Researchers want to study this disease to help the government better protect the health of people in Sibirila.

Objectives:

\- To find out how many people in Sibirila have ever had Lassa fever. Also, to measure how many people get the disease every year.

Eligibility:

\- People age 6 months and older who are residents of Soromba, Bamba, or Banzana with no plans to relocate within 1 year.

Design:

* Households will be randomly selected to participate in the study.
* Participants will have up to 20 drops of blood collected from the finger or heel.
* Participants will be asked about their age. They will be asked if they have ever had a fever and if they have ever seen mice in or around their home.
* Researchers will come back in 1 year and take another drop of blood from the participant. Participants will be asked the same questions.
* If a participant has a fever at any time during the year, he or she should go to the health center. Researchers

will collect a few drops of blood to test for Lassa fever.

...

Conditions

  • Lassa Virus Infection

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Heinrich U Feldmann, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-05
Primary Completion
2016-10-31
Completion
2018-10-22

Countries

  • Mali

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02311387 on ClinicalTrials.gov